3 Themes and Takeaways From FDA’s Draft Guidance on DCTs

Date Published:

The FDA just released draft guidance on decentralized clinical trials (DCTs). Our clinical science and trial optimization experts provide a summary of its key themes and offer perspective in this white paper. You’ll learn about:

  • Applications for technology in DCTs
  • Considerations for investigator oversight
  • Preserving data precision and integrity

Read the paper to find out how this guidance might inform your next study.

Download Now